Update on Sexually Transmitted Infections

September 17-20, 2007; Chicago, Illinois

David N. Fisman, MD, MPH, FRCP(C)


February 28, 2008

In This Article

Update on Sexually Transmitted Infections

Sexually transmitted infections (STIs) are the most common infectious diseases of public health importance in North America. Although these infections are important causes of acute morbidity and hospitalization, they also contribute to burden of disease as a result of late, chronic complications, including infertility, genital tract scarring and related conditions (infertility, ectopic pregnancy, strictures), psychological distress, and malignancy.

The past decade has seen an explosion in nucleic acid-based testing methodologies that permit easy identification of infection with fastidious or nonculturable microorganisms, allow testing on noninvasively collected specimens (eg, urine), and allow rapid throughput and pooled testing methods. These advances have led to a vastly improved understanding of the epidemiology of these diseases, and have also spawned a variety of novel public health strategies for their control.

A symposium providing an update on new challenges in, and diagnostic methods for, STIs was presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago, Illinois, on September 18, 2007. The symposium was moderated by Dr. Charlotte Gaydos of Johns Hopkins University in Baltimore, Maryland, and by Dr. Jorgen Jensen of the Statens Serum Institut in Copenhagen, Denmark.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: